NEWS
View news from our Featured Companies.
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
ATHENS, Greece, April 06, 2026 (GLOBE NEWSWIRE) -- TEN Ltd. (NYSE: TEN) ("TEN" or the "Company"), a leading diversified crude, product and LNG tanker operator, today announced that its Board of Directors declared the regular quarterly cash dividend of approximately...
ARIANNE PHOSPHATE CLOSES ON AGREEMENT TO EXTEND ITS CREDIT FACILITIES
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQB (USA)SAGUENAY, QC, April 1, 2026 /CNW/ - Arianne Phosphate Inc. (the "Company" or "Arianne") (TSXV: DAN) (OTCQB: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Intelligent Protection Management Corp. Enters into Strategic Collaboration with MASORI Therapeutics
IPM to offer "MASORI GO" to clients to facilitate seamless integration with workflows and tools to accelerate development and engagement JERICHO, NY / ACCESS Newswire / April 1, 2026 / Intelligent Protection Management Corp. ("IPM," "we," "us," "our" or the "Company")...
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
Encouraging Phase 2 HIT data and recent FDA feedback support continued advancement of CAD-1005 as Cadrenal's near-term development priority; broader 12-LOX platform remains a longer-term opportunityPONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal...
PolyPid Initiates D-PLEX NDA Submission to the FDA
PolyPid Submits First Modules as Part of Rolling NDA Review; Completion expected in Second Quarter of 2026 U.S. Commercialization Partnership Negotiations on Track PETACH TIKVA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the...
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
- Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for schizophrenia - - Current data package highlights well-tolerated long-term safety profile, broad-spectrum clinical...
Precision Optics Corporation, Inc. Announces Pricing of Upsized $10 Million Public Offering of Common Stock
GARDNER, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the pricing of its previously...
Precision Optics Corporation, Inc. Announces Proposed Public Offering of Common Stock
GARDNER, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it is commencing an...
ARIANNE PHOSPHATE TO PRESENT AT THE LYTHAM PARTNERS 2026 INDUSTRIALS & BASIC MATERIALS INVESTOR SUMMIT ON APRIL 1, 2026
DAN: TSX-V (Canada) JE9N: FSE (Germany) DRRSF: OTCQB (USA)SAGUENAY, QC, March 26, 2026 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQB: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Comstock Inc. Announces 2026 Annual Meeting
VIRGINIA CITY, Nev., March 26, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") is pleased to announce that its 2026 Annual Meeting of Shareholders has been scheduled for Thursday, May 28, 2026, starting at 9:00 a.m. Pacific Daylight...
Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026
VIRGINIA CITY, Nev., March 25, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit, taking...
Comstock Announces Full Year 2025 Achievements and Results
Expands Board as Company Accelerates Growth in Solar Recycling and Critical Metals RecoveryVIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock," "our" and the "Company"), today announced its full year 2025 results, 2025...
Comstock Inc. Appoints Three New Independent Directors as Company Accelerates Growth in Solar Recycling and Critical Metals Recovery
Donald A. Colvin, Steven Y. Pei and Robert M. Spence Appointed as Independent DirectorsVIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" or the "Company"), a leader in converting under-utilized natural resources into...
LiqTech Secures First U.S. Commercial Pool Order for Three QlariFlow™ Systems
BALLERUP, Denmark, March 23, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (Nasdaq: LIQT), a leading clean technology company specializing in advanced filtration systems, has received its first commercial pool order in the United States for three...
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
CUPERTINO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous...
Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Conference call will be held today, Thursday, March 19 at 10:00 am ET Woburn, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic...
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results
Conference call will be held today, Thursday, March 19 at 9:00 am ETCARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
CUPERTINO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous...
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
CUPERTINO, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous...
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced that...
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX ‘s New Drug Application
FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the...
ARIANNE PHOSPHATE ENGAGES GLOBAL ONE MEDIA FOR DIGITAL COMMUNICATIONS
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQB (USA)SAGUENAY, QC, March 17, 2026 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQB: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
Comstock Inc. to Host Q4 2025 Earnings Call and Business Update
VIRGINIA CITY, Nev., March 16, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" and the "Company") is pleased to announce that the Company's Executive Chairman & CEO, Corrado De Gasperis, and CFO, Judd Merrill will be providing an overview of our...
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38th Annual Roth Conference. Iradimed's CEO, Roger Susi, and CFO, Jack Glenn, will host one-on-one meetings between company management...
IPM to Participate in the 38th Annual ROTH Conference March 22-24, 2026
JERICHO, NY / ACCESS Newswire / March 12, 2026 / Intelligent Protection Management Corp. ("IPM" or the "Company") (NASDAQ:IPM), a managed technology solutions provider focused on enterprise cybersecurity and cloud infrastructure, today announced that the Company's...